Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease.

Gucalp A, Zhou XK, Cook ED, Garber JE, Crew KD, Nangia JR, Bhardwaj P, Giri DD, Elemento O, Verma A, Wang H, Lee JJ, Vornik LA, Mays C, Weber D, Sepeda V, O'Kane H, Krasne M, Williams S, Morris PG, Heckman-Stoddard BM, Dunn BK, Hudis CA, Brown PH, Dannenberg AJ.

Cancer Prev Res (Phila). 2018 Apr;11(4):203-214. doi: 10.1158/1940-6207.CAPR-17-0354. Epub 2018 Feb 16.

2.

Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer.

Kim J, Davis JW, Klein EA, Magi-Galluzzi C, Lotan Y, Ward JF, Pisters LL, Basler JW, Pettaway CA, Stephenson A, Li Ning Tapia EM, Efstathiou E, Wang X, Do KA, Lee JJ, Gorlov IP, Vornik LA, Hoque AM, Prokhorova IN, Parnes HL, Lippman SM, Thompson IM, Brown PH, Logothetis CJ, Troncoso P.

EBioMedicine. 2016 May;7:85-93. doi: 10.1016/j.ebiom.2016.03.047. Epub 2016 Apr 7.

3.

Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer.

Arun BK, Gong Y, Liu D, Litton JK, Gutierrez-Barrera AM, Jack Lee J, Vornik L, Ibrahim NK, Cornelison T, Hortobagyi GN, Heckman-Stoddard BM, Koenig KB, Alvarez RR, Murray JL, Valero V, Lippman SM, Brown P, Sneige N.

Breast Cancer Res Treat. 2016 Jul;158(1):67-77. doi: 10.1007/s10549-016-3849-1. Epub 2016 Jun 10.

4.

Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer.

Crew KD, Brown P, Greenlee H, Bevers TB, Arun B, Hudis C, McArthur HL, Chang J, Rimawi M, Vornik L, Cornelison TL, Wang A, Hibshoosh H, Ahmed A, Terry MB, Santella RM, Lippman SM, Hershman DL.

Cancer Prev Res (Phila). 2012 Sep;5(9):1144-54. doi: 10.1158/1940-6207.CAPR-12-0117. Epub 2012 Jul 24.

5.

Bupropion in the treatment of outpatients with asthma and major depressive disorder.

Brown ES, Vornik LA, Khan DA, Rush AJ.

Int J Psychiatry Med. 2007;37(1):23-8.

PMID:
17645195
6.

Management of comorbid bipolar disorder and substance abuse.

Vornik LA, Brown ES.

J Clin Psychiatry. 2006;67 Suppl 7:24-30. Review.

7.

Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials.

Perlis RH, Welge JA, Vornik LA, Hirschfeld RM, Keck PE Jr.

J Clin Psychiatry. 2006 Apr;67(4):509-16. Review.

PMID:
16669715
8.

Bipolar disorder: quality of life and the impact of atypical antipsychotics.

Vornik LA, Hirschfeld RM.

Am J Manag Care. 2005 Oct;11(9 Suppl):S275-80. Review.

9.

Bipolar disorder--costs and comorbidity.

Hirschfeld RM, Vornik LA.

Am J Manag Care. 2005 Jun;11(3 Suppl):S85-90. Review.

10.

Recognition and diagnosis of bipolar disorder.

Hirschfeld RM, Vornik LA.

J Clin Psychiatry. 2004;65 Suppl 15:5-9. Review.

11.

Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine.

Hirschfeld RM, Vornik LA.

J Clin Psychiatry. 2004;65 Suppl 4:46-52. Review.

12.

The power of the spoken word: sociolinguistic cues influence the misinformation effect.

Vornik LA, Sharman SJ, Garry M.

Memory. 2003 Jan;11(1):101-9.

PMID:
12653492

Supplemental Content

Loading ...
Support Center